Access cutting-edge based on the provided information, i cannot determine a primary patient-facing medical condition. the study title mentions "peg fusion" which appears to be a treatment technique, and the only condition listed is "drug:ntx-001" which is a drug identifier rather than a medical condition. without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Richmond location
Access based on the provided information, i cannot determine a primary patient-facing medical condition. the study title mentions "peg fusion" which appears to be a treatment technique, and the only condition listed is "drug:ntx-001" which is a drug identifier rather than a medical condition. without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related based on the provided information, i cannot determine a primary patient-facing medical condition. the study title mentions "peg fusion" which appears to be a treatment technique, and the only condition listed is "drug:ntx-001" which is a drug identifier rather than a medical condition. without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. treatment provided free
Check if you qualify for this based on the provided information, i cannot determine a primary patient-facing medical condition. the study title mentions "peg fusion" which appears to be a treatment technique, and the only condition listed is "drug:ntx-001" which is a drug identifier rather than a medical condition. without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. clinical trial in Richmond, VA
No-Cost Study Care
Local to Richmond
Convenient for VA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The overall objective of this study is to determine the safety of PEG fusion when used with primary repair or reconstruction in patients with an acute upper extremity peripheral nerve injury. PEG is safe and effective for extending the half-life of circulating pharmaceutical products, when used in conjunction with a topical hemostatic agent in surgical wounds, and when used as a colon cleanser for endoscopic surgical procedures. However, PEG fusion has not been rigorously tested as a safe reagen
Sponsor: Major Extremity Trauma Research Consortium
Yes, this clinical trial (NCT04789044) has an active research site in Richmond, VA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for based on the provided information, i cannot determine a primary patient-facing medical condition. the study title mentions "peg fusion" which appears to be a treatment technique, and the only condition listed is "drug:ntx-001" which is a drug identifier rather than a medical condition. without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. treatment options in Richmond, VA, this clinical trial (NCT04789044) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced based on the provided information, i cannot determine a primary patient-facing medical condition. the study title mentions "peg fusion" which appears to be a treatment technique, and the only condition listed is "drug:ntx-001" which is a drug identifier rather than a medical condition. without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all based on the provided information, i cannot determine a primary patient-facing medical condition. the study title mentions "peg fusion" which appears to be a treatment technique, and the only condition listed is "drug:ntx-001" which is a drug identifier rather than a medical condition. without additional clinical context or a proper medical indication, there is insufficient information to extract a patient-searchable condition. clinical trials near you to find additional studies recruiting in your area.
See all heart attack clinical trials recruiting in Richmond — not just this study.
Browse Heart Attack Trials in Richmond →